COCA-COLA CO/THE (KO)       60.6  +0.58 (+0.97%)

60.6  +0.58 (+0.97%)

US1912161007 - Common Stock - Premarket: 60.72 +0.12 (+0.2%)


Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to KO. KO was compared to 40 industry peers in the Beverages industry. KO has a great profitability rating, but there are some minor concerns on its financial health. KO is quite expensive at the moment. It does show a decent growth rate.




Profitability

Profitability Rating

8

KO's Return On Assets of 10.29% is amongst the best of the industry. KO does better than the industry average Return On Assets of 7.60%.
KO's Return On Equity of 39.59% is amongst the best returns of the industry. KO outperforms 86% of its industry peers. The industry average return on equity is 17.14%.

KO's Profit Margin of 22.19% is amongst the best returns of the industry. KO outperforms 100% of its industry peers. The industry average Profit Margin is 10.31%.
The Piotroski-F score of KO is 7.00. This is a strong score and indicates good health and profitability for KO.
VS Industry

ROA (10.29%) VS Industry: 78% outperformed.

0.41
26.63

ROE (39.59%) VS Industry: 86% outperformed.

1.21
51.96

Profit Margin (22.19%) VS Industry: 100% outperformed.

1.06
22.19

Valuation

Valuation Rating

0

The Price/Earnings Ratio is 24.44, which indicates a rather expensive current valuation of KO.
With a Forward Price/Earnings Ratio of 22.65, KO is valued rather expensively.
With a price book ratio of 10.88, KO is valued correctly.
Compared to an average industry Price/Earning Ratio of 20.96, KO is valued slightly more expensive.

The high PEG Ratio, which compensates the Price/Earnings for growth, indicates KO does not grow enough to justify the current Price/Earnings ratio.
When comparing the price book ratio of KO to the average industry price book ratio of 2.70, KO is valued more expensive than its industry peers. 90% of the companies listed in the same industry are valued cheaper.
When comparing the Enterprise Value to EBITDA ratio of KO to the average industry ratio of 14.77, KO is valued more expensive than its industry peers.
VS Industry

Price/Earnings (24.44) VS Industry: 39% outperformed.

76.00
2.34

Price/Book (10.88) VS Industry: 10% outperformed.

394.14
0.19

Enterprise Value/ EBITDA (21.3) VS Industry: 21% outperformed.

171.95
6.43

Growth

Growth Rating

5

The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
KO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.25%.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
The Earnings Per Share has been growing slightly by 6.44% over the past year.

KO shows a small growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 5.36% yearly.
The Earnings Per Share is expected to grow by 7.89% on average over the next 5 years.
The Revenue has been growing slightly by 3.50% on average over the past 5 years.
The Revenue is expected to grow by 5.37% on average over the next 5 years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS5.36% 5.53% 6.44% 7.87% 7.89% 7.8% 7.89%
Revenue3.5% 4.89% 11.25% 5.05% 5.15% 5.37% N/A

Health

Health Rating

5

An Altman-Z score of 4.30 indicates that KO is not in any danger for bankruptcy at the moment.
The Altman-Z score of KO is much better than the industry average of 3.03.
KO has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for KO.
KO has a Current Ratio of 1.15. This is a normal value and indicates that KO is financially healthy and should not expect problems in meeting its short term obligations.

KO has a Quick Ratio comparable to the industry average, which is at 0.90.
Compared to an average industry Current Ratio of 1.64, KO is worse placed to pay its short term obligations than its industry peers.
KO has a Quick Ratio of 1.15. This is a bad value and indicates that KO is not financially healthy enough and could expect problems in meeting its short term obligations.
Compared to an average industry Debt to Equity Ratio of 0.67, KO is requires more financing than its industry peers. 90% of its industry peers have a better Debt to Equity Ratio.
VS Industry

Debt/Equity (1.51) VS Industry: 10% outperformed.

4.44
0.00

Quick Ratio (0.93) VS Industry: 53% outperformed.

0.19
6.04

Current Ratio (1.15) VS Industry: 33% outperformed.

0.47
7.07

Altman-Z (4.3) VS Industry: 64% outperformed.

-122.08
32.07

Dividend

Dividend Rating

6

KO's Dividend Yield is a higher than the industry average which is at 2.22.
KO's Dividend Yield is a higher than the S&P500 average which is at 2.55.
The dividend of KO is growing, but earnings are growing more, so the dividend growth is sustainable.
KO has paid a dividend for at least 10 years, which is a reliable track record.

With a Yearly Dividend Yield of 3.11%, KO has a reasonable but not impressive dividend return.
The dividend of KO has a limited annual growth rate of 3.05%.
79.82% of the earnings are spent on dividend by KO. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (3.11%) VS Industry: 75% outperformed.

0.41
17.14

COCA-COLA CO/THE60.6

NYSE:KO (3/20/2023, 8:20:06 PM)+0.58 (+0.97%)

Premarket: 60.72 +0.12 (+0.2%)

Chartmill FA Rating
GICS Sector Consumer Staples
GICS IndustryGroup Food, Beverage & Tobacco
GICS Industry Beverages
Earnings (Last) 02-14 2023-02-14/bmo Earnings (Next) 04-24 2023-04-24/bmo
Inst Owners 72.06% Inst Owner Change 3.01%
Ins Owners 0.07% Ins Owner Change 34.65%
Market Cap 262.20B Analysts 80.56
Price Target 70.01 (15.53%)

Dividend
Industry RankSector Rank
Dividend Yield 3.11%
Dividend Growth(5Y) 3.05% DP 79.82%
Div Incr Years 19 Div Non Decr Years 19
Ex-Date 03-16 2023-03-16 (0.46)

Surprises & Revisions
EPS beat(2) 1 Avg EPS beat(2) 1.33%
Min EPS beat(2) -2.53% Max EPS beat(2) 5.18%
EPS beat(4) 3 Avg EPS beat(4) 2.87%
Min EPS beat(4) -2.53% Max EPS beat(4) 7.17%
Revenue beat(2) 1 Avg Revenue beat(2) 0.1%
Min Revenue beat(2) -1.89% Max Revenue beat(2) 2.09%
Revenue beat(4) 3 Avg Revenue beat(4) 1.98%
Min Revenue beat(4) -1.89% Max Revenue beat(4) 4.12%
PT rev (1m) 0.23% PT rev (3m) 3.14%
EPS NQ rev (1m) 2.25% EPS NQ rev (3m) 3.6%
EPS NY rev (1m) 2.56% EPS NY rev (3m) 2.56%
Revenue NQ rev (1m) 2.24% Revenue NQ rev (3m) 2.91%
Revenue NY rev (1m) 2.42% Revenue NY rev (3m) 2.42%

Valuation
Industry RankSector Rank
PE 24.44
Fwd PE 22.65
P/S 6.1
P/FCF 27.5
P/OCF 23.8
P/B 10.88
P/tB N/A
EV/EBITDA 21.3
EPS(TTM) 2.48 EY 4.09%
EPS(NY) 2.68 Fwd EY 4.41%
FCF(TTM) 2.2 FCFY 3.64%
OCF(TTM) 2.55 OCFY 4.2%
SpS 9.94 BVpS 5.57
TBVpS -2.2 PEG (NY) 3.1
PEG (5Y) 4.56

Profitability
Industry RankSector Rank
ROA 10.29%
ROE 39.59%
ROIC 12.93%
ROICexc 15.29%
ROICexgc 32.35%
OM 28.21%
PM 22.19%
GM 58.14%
ROICexgc(3y) 28.02% ROICexcg growth 3Y 7.58%
ROICexcg growth 5Y 8.4% ROICexc(3y) 13.81%
ROICexc growth 3Y 2.41% ROICexc growth 5Y 0.57%
OM growth 3Y 0.07% OM growth 5Y 0.75%
PM growth 3Y -2.5% PM growth 5Y 45.13%
GM growth 3Y -1.46% GM growth 5Y -1.31%
F-Score 7 Asset Turnover 0.46

Health
Industry RankSector Rank
Debt/Equity 1.51
Debt/FCF 4.11
Debt/EBITDA 2.92
Cap/Depr 117.78%
Profit Quality 99.92%
Current Ratio 1.15
Quick Ratio 0.93
Altman-Z 4.3
F-Score 7 WACC 7.55%
ROIC/WACC 4.28 Cap/Depr(3y) 96.18%
Cap/Depr(5y) 116.31% Profit Quality(3y) 109%
Profit Quality(5y) 103.17%

Growth
EPS 1Y 6.44% EPS 3Y 5.53%
EPS 5Y 5.36% EPS growth Q2Q 0%
EPS Next Y 7.87% EPS Next 2Y 7.89%
EPS Next 3Y 7.8% EPS Next 5Y 7.89%
Revenue growth 1Y 11.25% Revenue growth 3Y 4.89%
Revenue growth 5Y 3.5% Revenue growth Q2Q 6.98%
Revenue Next Year 5.05% Revenue Next 2Y 5.15%
Revenue Next 3Y 5.37% Revenue Next 5Y N/A
EBIT growth 1Y 8.75% EBIT growth 3Y 4.97%
EBIT growth 5Y 4.28% EBIT Next Year 7.53%
EBIT Next 3Y 7.55% EBIT Next 5Y N/A
FCF growth 1Y -15.31% FCF growth 3Y 4.24%
FCF growth 5Y 12.5% OCF growth 1Y -12.73%
OCF growth 3Y 1.71% OCF growth 5Y 9.37%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA